Company Filing History:
Years Active: 2025
Title: Elizabeth W. Jeffords: Innovator in Ocular Therapeutics
Introduction
Elizabeth W. Jeffords is a prominent inventor based in Hillsborough, CA (US). She has made significant contributions to the field of ocular medicine, particularly in the treatment of inflammatory diseases affecting the eye. Her innovative approach has the potential to improve patient outcomes and enhance the safety of ocular therapies.
Latest Patents
Elizabeth holds a patent for "Methods of treating ocular inflammatory diseases." This invention relates to the administration of ophthalmic pharmaceutical compositions of roflumilast. The administration of these compositions can provide significant immunomodulatory and anti-inflammatory activity compared to existing therapies, including corticosteroids and antihistamines. This advancement offers an improved safety and convenience profile for patients.
Career Highlights
Throughout her career, Elizabeth has demonstrated a commitment to advancing ocular health. Her work at Iolyx Therapeutics, Inc. has positioned her as a leader in the development of innovative treatments for ocular inflammatory diseases. With her expertise, she continues to push the boundaries of what is possible in ocular therapeutics.
Collaborations
Elizabeth collaborates with talented professionals in her field, including Hovhannes John Gukasyan and Rozemarijn Verhoeven. These partnerships enhance the research and development efforts at Iolyx Therapeutics, Inc., fostering an environment of innovation and discovery.
Conclusion
Elizabeth W. Jeffords is a trailblazer in the field of ocular therapeutics, with her patent for treating ocular inflammatory diseases showcasing her innovative spirit. Her contributions have the potential to transform patient care and set new standards in ocular medicine.